Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults
|
|
- Theodore Murphy
- 5 years ago
- Views:
Transcription
1 Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen J 3, Bilo G 4, Salvi P 4, Aristizabal D 2, Parati G 1,4 1. Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milan, Italy. 2. Clinical and Research Center, SICOR, Medellín, Colombia. 3. Corporación para Investigaciones Biologicas, Medellín, Colombia. 4. Department of Cardiology, S. Luca Hospital, Istituto Auxologico Italiano, Milan, Italy
2 Aim: To explore the relationship of IR with: 1-HR and BPV within the 24h 2-Cardiac BRS and Indices of autonomic CV modulation
3 Frequency (number of individuals) Methods: subjects Population study Medellín, Colombia Prevalence of CV risk factors in (n=800). Subjects with DBP 30 percentile of DBP distribution curve Diastolic BP (mmhg)
4 Methods: Subjects Further inclusion criteria : Normotensive 24h mean SBP/DBP 107/69 mmhg No history of HT or taking antihypertensive treatment Normoglicemic mean fasting glucose 76.1± 10.0 mg/dl Non-obese mean BMI ± 3.66 Kg/m 2 Healthy adults mean age 48±10 yrs, no previous history of CVD. A total of 90 subjects were included
5 Methods: Assessment of IR HOMA-Index = ((glycemia (mg/dl)/18) x insulinemia(uu/ml)/22.5). subjects were classified into tertiles based on HOMA-IR values Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):
6 Methods: BP measurement (24h ABPM) HR, SBP and DBP levels were averaged over the 24-h, day- and night-time Day-to-night dipping of HR, SBP and DBP were calculated Daytime Night-time Mobil-O-Graph NG, IEM, Stolberg, Germany.
7 Methods: assessment of BPV within the 24h BPV was assessed separately for SBP and DBP as: 24-h SD Day-time SD Night-time SD Weighted 24h SD (wsd) Bilo G, Parati G, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J hypertens. 2007;25(10):
8 Methods: assessment of autonomic cardiac modulation Protocol of hemodynamic assessment: 10 min beat-to beat BP and RRI recordings in supine position (Task Force Monitor, Graz, Austria) Time (min)
9 Methods: assessment of cardiac BRS Sequence method (Parati et al. 1988) Up Sequence Down Sequence
10 Methods: indices of autonomic cardiac modulation Frequency domain analysis of HRV (Spectral technique) LF, HF and RRI total power (PSD, ms 2 ) LF and HF in normalized units (%) LF/HF ratio Parati G, et al LF HF
11 Methods: Statistical analysis subjects were classified into HOMA-IR tertiles ANOVA to test differences in clinical, autonomic and hemodynamic parameters among tertiles of HOMA-Index. ANCOVA Adjusting for age, sex, smoking, and BMI
12 Results: Clinical characteristics by tertiles of HOMA-Index Variable All T1 (<0.94) (n=32) T2 ( ) (n=28) T3 (>1.90) (n=30) P value Age (years) ± ± ± ± BMI ± ± ± ± Sex (Male, %) Smokers (%) Fasting glucose (mg/dl) 76.17± ± ± ± Insulin (mu/ml) 8.7 ± ± ± ± HOMA-Index 1.69 ± ± ± ± Total Cholesterol (mg/dl) 201.9± ± ± ± HDL Cholesterol (mg/dl) 45.3 ± ± ± ± LDL Cholesterol (mg/dl) 129.2± ± ± ± Triglycerides (mg/dl) 153.6± ± ± ±
13 Results: Mean HR and BP levels by tertiles of HOMA (from 24h ABPM) Variable* T1 (<0.94) (n=32) T2 ( ) (n=28) T3 (>1.90) (n=30) adjusted p value Day HR (bpm) 71.8 ± ± ± Day SBP (mmhg) ± ± ± Day DBP (mmhg) 73.0 ± ± ± Day PP (mmhg) 34.8 ± ± ± Night HR (bpm) 59.3 ± ± ± Night SBP (mmhg) 93.6 ± ± ± Night DBP (mmhg) 63.5 ± ± ± Night PP (mmhg) 30.1 ± ± ± h HR (bpm) 68.3 ± ± ± h SBP (mmhg) ± ± ± h DBP (mmhg) 70.2 ± ± ± h PP (mmhg) 33.5 ± ± ±
14 Results: HR and BPV (from 24h ABPM) by tertiles of HOMA Variable* T1 (<0.94) (n=32) T2 ( ) (n=28) T3 (>1.90) (n=30) Adjust ed p value Day SBP SD (mmhg) 9.7 ± ± ± Day DBP SD (mmhg) 6.4 ± ± ± Day HR SD (bpm) 10.1 ± ± ± Night SBP SD (mmhg) 9.6 ± ± ± Night DBP SD (mmhg) 6.5 ± ± ± Night HR SD (bpm) 5.3 ± ± ± h SBP SD (mmhg) 11.9 ± ± ± h DBP SD (mmhg) 8.0 ± ± ± h HR SD (bpm) 11.1 ± ± ± SBP wsd 9.7 ± ± ± DBP wsd 6.5 ± ± ± HR dipping (bpm) 13.1 ± ± ± SBP dipping (mmhg) 14.4 ± ± ± DBP dipping (mmhg) 9.5 ± ± ±
15 Results: cardiac BRS by tertiles of HOMA-IR p= 0,045 p= 0,042 p= 0,045
16 Results: indices of autonomic CV modulation by tertiles of HOMA
17 Results: indices of autonomic CV modulation by tertiles of HOMA
18 Results: summary Insulin resistance was associated with: Ambulatory HR and SBP during day, night and 24h SBP variability (Day SBP SD, and 24h SBP wsd) RRI, HRV and HR dipping Cardiac BRS Indices of sympathetic CV modulation (LF/HF ratio) indices of parasympathetic CV modulation ( HF and TP)
19 CV outcomes and mortality Conclusion Insulin Resistance BRS Central Sympathetic drive HR and SBP during day, night and 24h BP variability and HRV HR dipping
20 Thanks for your attention.
Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation
Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation Ochoa JE 1,2, Correa M 1,5, Gallo J 3,5, McEwen J 1,3,
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationDeclaration of conflict of interest
Declaration of conflict of interest Prevalence and main features of resistant hypertension in Central and Eastern Europe: data from the G. Brambilla 1, G. Seravalle 2, R. Cifkova 3, C. Farsang 4, S. Laurent
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationLong-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study
The EPI/NPAM Spring 2014 Scientific Sessions, Hilton San Francisco Union Square, San Francisco, CA Northwestern Mar. 18-21, 2014 University Feinberg School of Medicine Long-term Blood Pressure Variability
More information24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting
2017 Dementia 24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting Wat gebruiken in de klinische praktijk? Jan A. Staessen, MD, PhD KU Leuven jan.staessen@kuleuven.be BPM Key messages to be made
More informationProf. Renata Cífková, MD, CSc.
Prof. Renata Cífková, MD, CSc. Head of the Department of Preventive Cardiology, Thomayer Teaching Hospital, Prague Focuses on arterial hypertension epidemiology, clinical trials, target organ damage prevention
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationSTATE OF THE ART BP ASSESSMENT
STATE OF THE ART BP ASSESSMENT PROFESSOR MOLECULAR PHARMACOLOGY CONWAY INSTITUE UNIVERSITY COLLEGE DUBLIN CO-CHAIRMAN BLOOD PRESCSURE MANAGEMENT IN LOW RESOURCE SETTINGS CENTRE FOR INTERNATIONAL HUMANITARIAN
More informationUse and Interpretation of Home Blood Pressure Monitoring
Use and Interpretation of Home Blood Pressure Monitoring BLOOD PRESSURE in year 2015 PARAMETERS TODAY Gianfranco Parati University of Milano-Bicocca & Ospedale S.Luca, IRCCS, Istituto Auxologico Italiano
More informationAUTONOMIC FUNCTION IS A HIGH PRIORITY
AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationKey words: HRV db, Family history of Hypertension, Heart Rate, Blood pressure
(14) EFFECT OF DEEP BREATHING ON HEART RATE VARIABILITY IN NORMOTENSIVE MALE OFFSPRING S OF HYPERTENSIVE PARENTS Dr. H. C. Veena 1, Dr. Vijayanath Itagi 2, Dr. R. H. Takalikar 3, Dr. R. S. Patil 4 1. Post
More informationDeprivation Study. The Freiburg Study
The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism
More informationZi-Hui Tang, Fangfang Zeng, Zhongtao Li, and Linuo Zhou
Diabetes Research, Article ID 215473, 7 pages http://dx.doi.org/10.1155/2014/215473 Clinical Study Association and Predictive Value Analysis for Resting Heart Rate and Diabetes Mellitus on Cardiovascular
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationRisk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication
41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationGATEWAY Trial. Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension
GATEWAY Trial Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationSecondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating
More informationHow do we diagnose hypertension today? Presentation Subtitle
How do we diagnose hypertension today? Presentation Subtitle Renata Cífková Case 1 JM, a 64-year-old lady referred to our center because of undesirable effects of her antihypertensive medication Personal
More informationEffects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial
Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators DISCLOSURE
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationEffects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial
Effects of Bariatric Surgery in Obese Patients with Hypertension The GATEWAY Randomized Trial Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators DISCLOSURE
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationThe modification of heart rate variability in normal, overweight and type 2 diabetic individuals.
1 The modification of heart rate variability in normal, overweight and type 2 diabetic individuals. Nicholas J. Sjoberg, B.Sci(Hons) Discipline of Physiology University of Adelaide Submitted in fulfilment
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationSUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics
Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics
More informationIndividual Study Table Referring to Item of the Submission: Volume: Page:
2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationDECLARATION OF CONFLICT OF INTEREST. None
DECLARATION OF CONFLICT OF INTEREST None Dietary changes and its influence on cardiovascular diseases in Asian and European countries Problems of Eastern European countries for cardiovascular disease prevention
More informationAdolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center
Adolescent Hypertension Roles of obesity and hyperuricemia Daniel Landau, MD Pediatrics, Soroka University Medical Center Blood Pressure Tables BP standards based on sex, age, and height provide a precise
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationChapter-V. Summary, Conclusions and Recommendations
Summary, Conclusions and Recommendations INTRODUCTION The work included in this thesis entitled, Circadian heart rate and blood pressure variability in apparently healthy subjects using ABPM has been divided
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationChapter 2 Home (Self) Monitoring of Blood Pressure
Chapter 2 Home (Self) Monitoring of Blood Pressure Gianfranco Parati and Juan Eugenio Ochoa Introduction Elevated blood pressure (BP) levels represent the most important modifiable risk factor for cardiovascular
More informationThe Relationship Between Ambulatory Arterial Stiffness Index and Blood Pressure Variability in Hypertensive Patients
ORIGINAL ARTICLE DOI 10.4070/kcj.2011.41.5.235 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright 2011 The Korean Society of Cardiology Open Access The Relationship Between Ambulatory Arterial Stiffness
More informationHigh intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes Sophie Cassidy, s.cassidy@ncl.ac.uk 1) Concentric remodelling 1.2 * Eccentricity ratio
More informationObstructive sleep apnea and hypertension: why treatment does not consistently improve blood pressure?
Martino F. Pengo MD, PhD 7 & 8 décembre 2018, Berlin Obstructive sleep apnea and hypertension: why treatment does not consistently improve blood pressure? Sleep Disorder Center Department of Cardiovascular,
More informationWhite Coat Hypertension
White Coat Hypertension Giuseppe Mancia Guido Grassi Gianfranco Parati Alberto Zanchetti White Coat Hypertension An Unresolved Diagnostic and Therapeutic Problem Giuseppe Mancia Emeritus Professor University
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationCorrelation of nocturnal blood pressure pattern with dysautonomia in hypertensive patients with orthostatic hypotension
Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article Correlation of nocturnal blood pressure pattern with dysautonomia in hypertensive patients with orthostatic
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationWhen should blood pressure be lowered? Should treatment be guided by blood pressure values or total cardiovascular risk?
OF JOURNAL HYPERTENSION JH R RESEARCH Journal of HYPERTENSION RESEARCH www.hypertens.org/jhr Editorial J Hypertens Res (2016) 2(2):47 51 When should blood pressure be lowered? Should treatment be guided
More informationSupplementary Table 1. Patient demographics and baseline characteristics (treated patients).
Supplementary Table 1. Patient demographics and baseline characteristics (treated patients). Placebo (n=188) 10 mg (n=186) 25 mg (n=189) Total (n=563) Gender, n (%) Male 75 (40) 97 (52) 84 (44) 256 (45)
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationChapter-IV. Blood pressure and heart rate variability as function of ovarian cycle in young women
Blood pressure and heart rate variability as function of ovarian cycle in young women INTRODUCTION In human females, the menstrual cycle begins with the onset of menstrual flow on day 1. The menstrual
More informationDementia Retinal arteriolar narrowing and HT. What comes first?
Dementia 2016 Retinal arteriolar narrowing and HT What comes first? Jan A. Staessen, MD, PhD University of Leuven / Maastricht University jan.staessen@med.kuleuven.be / ja.staessen@maastrichtuniversity.nl
More informationReference ranges of circadian variation parameters of cardiac autonomic modulation in healthy employees: The Mannheim Industrial Cohort Studies
Reference ranges of circadian variation parameters of cardiac autonomic modulation in healthy employees: The Mannheim Industrial Cohort Studies Symposium 1031: Chronobiology Meets Psychophysiology: Revisiting
More informationSleep disorders & cardiovascular risk in chronic spinal cord injury
Sleep disorders & cardiovascular risk in chronic spinal cord injury PVA Summit Abdulghani Sankari, MD, PhD Email: asankari@dmc.org 2017 Disclosures Presenter has Federal and private foundations research
More informationFructose, Uric Acid and Hypertension in Children and Adolescents
Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion
More informationAssociation of 24 h systolic blood pressure variability and cardiovascular disease in patients with obstructive sleep apnea
Ke et al. BMC Cardiovascular Disorders (2017) 17:287 DOI 10.1186/s12872-017-0723-y RESEARCH ARTICLE Open Access Association of 24 h systolic blood pressure variability and cardiovascular disease in patients
More informationThe Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4)
The Indian Polycap Study 1 & 2 (TIPS 1 & 2) and The International Polycap Study 3 & 4 (TIPS 3 & 4) Denis Xavier MD, MSc Professor and Head, Pharmacology, St. John's Medical College Coordinator, Division
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationCATHETER-BASED RENAL DENERVATION INCREASES INSULIN SENSITIVITY AND IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT HYPERTENSION
CATHETER-BASED RENAL DENERVATION INCREASES INSULIN SENSITIVITY AND IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT HYPERTENSION F. Mahfoud, Ch. Ukena, B. Cremers, I. Kindermann, M. Kindermann, P.
More informationPROGNOSTIC VALUE OF OSTEOPROTEGERIN IN CHRONIC HEART FAILURE: THE GISSI-HF TRIAL
PROGNOSTIC VALUE OF OSTEOPROTEGERIN IN CHRONIC HEART FAILURE: THE GISSI-HF TRIAL Ragnhild Røysland MD 1,2, Serge Masson PhD 3, Torbjørn Omland MD, PhD, MPH 1,2, Valentina Milani MS 3, Mette Bjerre PhD
More informationORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods
Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,
More informationArbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia
THE VALUE OF 24 H HEART RATE VARIABILITY IN PREDICTING THE MODE OF DEATH IN PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION IN BETA-BLOCKING BLOCKING ERA Arbolishvili GN, Mareev VY Institute of Clinical
More informationMetabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI
Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Narbeh Melikian*, Ajay M Shah*, Martyn R Thomas, Roy Sherwood, Mark T
More informationRandomized Design of ALLHAT BP Trial
Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Lisinopril* *Wright JT, Dunn JK, Cutler JA et al. JAMA 2005:293:1595-1608. 42,418 High-risk hypertensive
More informationPrevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient
Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion
More informationThe Evolution To Treatment Of Hypertension With Advanced Formulation
The Evolution To Treatment Of Hypertension With Advanced Formulation Dr. Donald Ang MBChB (UK) FRCP (Edin) MD (UK) CCST Cardiology (UK) FESC (Europe) Consultant Cardiologist Island Hospital Penang High
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationAGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston
AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK Michael Smolensky, Ph.D. The University of Texas Austin & Houston Disclosures Partner: Circadian Ambulatory Diagnostics Consultant: Spot On Sciences
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationThe New Hypertension Guidelines
The New Hypertension Guidelines Joseph Saseen, PharmD Professor and Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus Disclosure Joseph Saseen reports no conflicts
More informationINCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS
INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS A.J. Scheen, J.C. Philips, M. Marchand Division of Diabetes, Nutrition
More informationCentral blood pressure variability is increased in hypertensive patients with target organ damage
Received: 30 August 2017 Revised: 7 October 2017 Accepted: 20 October 2017 DOI: 10.1111/jch.13172 ORIGINAL PAPER Central blood pressure variability is increased in hypertensive patients with target organ
More informationDECLARATION OF CONFLICT OF INTEREST. None to declare
DECLARATION OF CONFLICT OF INTEREST None to declare Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension Gino Seravalle Marco Volpe
More informationAmbulatory Blood Pressure Monitoring Clinical Practice Recommendations
Acta Medica Marisiensis 2016;62(3):350-355 DOI: 10.1515/amma-2016-0038 UPDATE Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Mako Katalin *, Ureche Corina, Jeremias Zsuzsanna University
More informationThe prevalence of obesity is continuously increasing among
Added Impact of Obesity and Insulin Resistance in Nocturnal Blood Pressure Elevation in Children and Adolescents Empar Lurbe, Isabel Torro, Francisco Aguilar, Julio Alvarez, Jose Alcon, Jose Maria Pascual,
More informationRelationships between adiposity and left ventricular function in adolescents: mediation by blood pressure and other cardiovascular measures
Relationships between adiposity and left ventricular function in adolescents: mediation by blood pressure and other cardiovascular measures H Taylor 1, C M Park 1, L Howe 2, A Fraser 2 D Lawlor 2, G Davey
More informationLONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM
LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM Riccardo Marsili, Pietro Iacconi, Massimo Chiarugi, Giampaolo Bernini*, Alessandra Bacca*, Paolo Miccoli Department
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationEffect of Postural Changes on Baroreflex Sensitivity: A study on the EUROBAVAR data set
Effect of Postural Changes on Baroreflex Sensitivity: A study on the EUROBAVAR data set Younhee Choi University of Rhode Island Department of ECE Kingston, RI 02881 USA choi.younhee@gmail.com Seok-Bum
More informationHypertension Management in Diabetic Patients
Hypertension Management in Diabetic Patients Park, Chang G, MD, PhD Cardiovascular Center, Guro Hospital, Korea University Medical School Contents (Treatment of 2 Cases) Type 2 Diabetes Mellitus Hypertension
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationHigh-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension
(2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationTalking about blood pressure
Talking about blood pressure Mrs Khan 56 BP 158/99 BMI 32 Total cholesterol 5.4 (HDL 0.8) HbA1c 43 She has been promising to do more exercise and eat more healthily for the last 2 years but her weight
More informationAdult Pre Participation Screening and Exercise Prescription Practicum
Adult Pre Participation Screening and Exercise Prescription Practicum Objectives of this exercise: To administer pre participation screening and risk stratification for clients To write an appropriate
More informationENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH
ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH I Jialal, MD, PhD. FRCPath.DABCC Robert E. Stowell Chair in Experimental Pathology Professor of Pathology and Medicine Director, Laboratory
More informationPreventing Cardiovascular Disease Stroke Primary Prevention Guidelines. John Potter Professor Ageing & Stroke Medicine University of East Anglia
Preventing Cardiovascular Disease Stroke Primary Prevention Guidelines John Potter Professor Ageing & Stroke Medicine University of East Anglia Preventing Cardiovascular Disease Stroke Primary Prevention
More informationEvaluation and Management of Hypertension in Women. Vesna D. Garovic, M.D. Moscow, Russia, December 2016
Evaluation and Management of Hypertension in Women Vesna D. Garovic, M.D. Moscow, Russia, December 2016 2016 MFMER 3508058-1 Women are not small men There is nothing as powerful as an idea whose time has
More informationSFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease
FLAVIOLA Targeted delivery of dietary flavanols for optimal human cell function: Effects on cardiovascular health SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease Flavanol
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationEuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice
EuroPRevent 2010 Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice G. De Backer Ghent University Ghent, Belgium May 5-8 2010, Prague Czech Republic G. De
More informationCardiovascular System and Health. Chapter 15
Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer
More informationWeb appendix: Supplementary material. Contents
Web appendix: Supplementary material Contents Appendix 1. Search terms... 2 Appendix 2.1. Parameters measured in studies included in the descriptive-analysis... 3 Appendix 2.2. Parameters measured in studies
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationBlood Pressure Monitoring in Chronic Kidney Disease
Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American
More informationEvidence of Baroreflex Activation Therapy s Mechanism of Action
Evidence of Baroreflex Activation Therapy s Mechanism of Action Edoardo Gronda, MD, FESC Heart Failure Research Center IRCCS MultiMedica Cardiovascular Department Sesto S. Giovanni (Milano) Italy Agenda
More information